Support and Resistance Levels
Past performance
About Wanbury Ltd Wanbury Ltd, initially known as Pearl Organics Limited, is a pharmaceutical company founded in August 1988. It focuses on pharmaceutical production and research. The company began API manufacturing at its first plant in Tarapur in 1992 and expanded by acquiring Brij Chemicals Pvt Ltd in 1995. A strategic alliance with Wyckoff Chemicals in 1996 facilitated API manufacturing in the US. Wanbury further expanded through mergers with Doctors Organic Chemicals Limited and Pharmaceutical Products of India Limited, enhancing its equity base and market presence.
The company developed a strategic association with Bravo Healthcare Ltd to source raw materials from China and established an international presence with offices in Zurich and the Middle East. Wanbury has launched several novel products, including 'Cdense Gems' and Myotol-F, targeting female infertility and polycystic ovarian syndrome. By restructuring its Formulation Division in 2013 and introducing products like Cal-K2 for osteoporosis management, Wanbury continues to innovate in the pharmaceutical industry.